Publication | Open Access

Associations Between Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blocker Use, Gastrointestinal Symptoms, and Mortality Among Patients With COVID-19

HypertensionCardiovascular DiseaseGastrointestinal PharmacologyAntihypertensive TherapyCardiovascular PharmacologyGastroenterologyGastrointestinal SymptomsPharmacotherapyPublic HealthMedicineEpidemiologyCovid-19Digestive System Diseases